Curi Bio Awarded Over $4.4M in NIH Grants to Advance Translational Science

/in , /by

SEATTLE —  Curi Bio, the industry leader in developing human stem cell-based platforms for drug discovery, proudly announces two recent SBIR grants worth $4.4 million from the National Institutes of Health (NIH) to support its pioneering work on implementing human models to advance discovery of the next generation of medicines. The first project will support […]

Read more →

Thermo Fisher Scientific Introduces New Chromosomal Microarray with Two-Day Turnaround Time to Increase Lab Productivity

/in , /by

Applied Biosystems™ CytoScan™ HD Accel array delivers the fastest chromosomal microarray analysis workflow in the industry and improved coverage CARLSBAD, Calif. — Thermo Fisher Scientific, the world leader in serving science, today announced the launch of a new chromosomal microarray designed to improve cytogenetic research lab productivity, efficiency and profitability with an industry-leading two-day turnaround […]

Read more →

Unchained Labs adds big-time horsepower with new CCO!

/in , , , , , , , , /by

Pleasanton, CA – Unchained Labs, the life science tools company that’s all about getting biologics and gene therapy researchers the right tools for the job, announced today that life sciences ace, Scott Thomas, has joined the Company as Chief Commercial Officer. Scott has some serious street cred when it comes to scaling life science commercial […]

Read more →

SOPHiA GENETICS Expands Relationship with Gustave Roussy

/in , , , , /by

Gustave Roussy uses SOPHiA DDM™ Platform to empower confident, data-driven medicine in the fight against cancer BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced the expansion of its relationship with Gustave Roussy, the leading cancer center in Europe. With the expanded relationship SOPHiA GENETICS will now further […]

Read more →

Twist Bioscience Releases 2023 ESG Report and Quantifies Carbon Footprint of Manufacturing a Single Gene

/in , , , /by

SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today released its environmental, social and governance (ESG) report for 2023, highlighting Twist’s approach to sustainability, social responsibility and commitment to ethics. “We took a big step forward in our […]

Read more →

MGI Partners with NGeneBio to Advance Precision Medicine

/in , /by

SEOUL, South Korea — MGI, a company committed to building core tools and technology to lead life science and NGeneBio, a company specializing in next-generation sequencing-based diagnostic have signed a memorandum of understanding (MOU) to expand the commercial access of NGeneBio’s cancer testing products globally. This strategic partnership will enable the integration of NGeneBio’s advanced diagnostic […]

Read more →

Oxford Nanopore Technologies and IQVIA collaborate to improve global health outcomes by driving access to nanopore sequencing

/in , /by

New collaboration aims to broaden access to nanopore sequencing technology to accelerate patient diagnosis and genomic research   Oxford Nanopore Technologies plc (Oxford Nanopore), the company delivering a new generation of nanopore-based molecular sensing technology, and IQVIA, a leading global provider of advanced analytics, technology solutions and clinical research services in healthcare and life sciences, has […]

Read more →

Bionano Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement

/in , , /by

SAN DIEGO — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has received a letter from the staff of the Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has regained compliance with Nasdaq’s minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing […]

Read more →

William P. Donnelly Appointed to Quanterix’s Board of Directors

/in , /by

BILLERICA, Mass. — Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced that it appointed William (Bill) P. Donnelly to its Board of Directors. Mr. Donnelly brings many years of senior leadership experience in the life science tools industry, including 21 years at Mettler-Toledo International Inc., […]

Read more →